Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
15 June 2021Website:
http://www.alzamend.comNext earnings report:
13 September 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 23:39:41 GMTDividend
Analysts recommendations
Institutional Ownership
ALZN Latest News
Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminate to create a sector filled with dozens of biotech stocks that have 10X potential, or better.
Turning $1,000 into $10,000 in a year in the stock market is undoubtedly a lofty goal. Make no bones about it, it's not particularly likely to happen.
What type of business is Alzamend Neuro?
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and AL002 that completed preclinical stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
What sector is Alzamend Neuro in?
Alzamend Neuro is in the Healthcare sector
What industry is Alzamend Neuro in?
Alzamend Neuro is in the Biotechnology industry
What country is Alzamend Neuro from?
Alzamend Neuro is headquartered in United States
When did Alzamend Neuro go public?
Alzamend Neuro initial public offering (IPO) was on 15 June 2021
What is Alzamend Neuro website?
https://www.alzamend.com
Is Alzamend Neuro in the S&P 500?
No, Alzamend Neuro is not included in the S&P 500 index
Is Alzamend Neuro in the NASDAQ 100?
No, Alzamend Neuro is not included in the NASDAQ 100 index
Is Alzamend Neuro in the Dow Jones?
No, Alzamend Neuro is not included in the Dow Jones index
When does Alzamend Neuro report earnings?
The next expected earnings date for Alzamend Neuro is 13 September 2024